Abeona Therapeutics, Inc.

Clinical trials sponsored by Abeona Therapeutics, Inc., explained in plain language.

Abeona Therapeutics, Inc. ABEO NASDAQ

Clinical-stage biopharmaceutical company developing gene and cell therapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

Gene therapy for 'Butterfly Skin' disease tracked for 15 years in major safety registry

Disease control Recruiting now

This registry follows people with recessive dystrophic epidermolysis bullosa (RDEB) who have been treated with prademagene zamikeracel, a gene therapy made from their own skin cells and surgically applied to wounds. The study monitors long-term safety and wound healing durability…

Sponsor: Abeona Therapeutics, Inc • Aim: Disease control

Last updated Jul 16, 2026 00:00 UTC

Abeona Therapeutics, Inc.

Gene therapy for 'Butterfly Skin' disease tracked for 15 years in major safety registry